Psychopharmacology

, Volume 220, Issue 3, pp 639–641 | Cite as

The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents

  • Josip Podobnik
  • Iris Foller Podobnik
  • Neda Grgic
  • Darko Marcinko
  • Nela Pivac
Letter to the Editors

References

  1. Abraham PF, Calabrese JR (2008) Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? J Affect Disord 111:21–30PubMedCrossRefGoogle Scholar
  2. Adityanjee RA, Brown E, Thuras P, Lee S, Schulz SC (2008) Quetiapine in patients with borderline personality disorder: an open-label trial. Ann Clin Psychiatry 20:219–226PubMedCrossRefGoogle Scholar
  3. Barzman DH, DelBello MP, Adler CM, Stanford KE, Strakowski SM (2006) The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s). J Child Adolesc Psychopharmacol 16:665–670PubMedCrossRefGoogle Scholar
  4. DeHert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU (2011) Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Neuropsychopharmacol 21:144–158CrossRefGoogle Scholar
  5. DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM (2009) A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord 11:483–493PubMedCrossRefGoogle Scholar
  6. Findling RL, Reed MD, O’Riordan MA, Demeter CA, Stansbrey RJ, Mcnamara NJ (2007) A 26-week open-label study of quetiapine in children with conduct disorder. J Child Adolesc Psychopharmacol 17:1–9PubMedCrossRefGoogle Scholar
  7. Zuddas A, Zanni R, Usala T (2011) Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies. Eur Neuropsychopharmacol 21:600–620PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Josip Podobnik
    • 1
  • Iris Foller Podobnik
    • 1
  • Neda Grgic
    • 1
  • Darko Marcinko
    • 2
  • Nela Pivac
    • 3
  1. 1.Department of PsychiatryPsychiatric Hospital for Children and Youth ZagrebZagrebCroatia
  2. 2.Department of PsychiatryUniversity Hospital Centre Zagreb, School of Medicine, University of ZagrebZagrebCroatia
  3. 3.Division of Molecular MedicineRudjer Boskovic InstituteZagrebCroatia

Personalised recommendations